In this issue:
Likelihood of progressing from nr-axSpA to r-axSpA
Examining the safety and efficacy of tofacitinib
Prevalence of PsA over the years
New novel MRI reporting system
The safety profile and efficacy of bimekizumab
Assessing the benefits of MTX
Factors influencing negative illness perception
Efficacy of namilumab
Tofacitinib versus adalimumab
Incidence of demyelinating disease
Please login below to download this issue (PDF)